Definitive Contract 75R60220C00001

Award Date 7/31/20
Potential Completion Date 7/30/25
Potential Value $34M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Gilead Sciences Inc. (Gilead) for Ending the HIV Epidemic - Pre-Exposure Prophylaxis (PrEP) Implementation and Dissemination Services. The contract has a firm fixed price and a potential value of $12,970,000.00. The work will be performed in Foster City, California. Gilead is a for-profit biopharmaceutical company that develops and commercializes...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Fenway Community Health Center, Inc., a non-profit organization, for $149,365.00 to provide biological specimens from HIV-positive men who are under or initiating integrase inhibitor-based antiretroviral therapy. The purpose is to develop and assess retroviral integrase, as integrase strand transfer inhibitor (INSTI)-based regimens are increasing in use and...
This federal contract award, valued at $90,772.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREZCOBIX 800 MG-150 MG tablets, a medication used to treat HIV infection. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
This is a $199,845 firm fixed-price delivery order contract awarded by the Department of Health and Human Services (HHS) to The Mayatech Corp, a minority-owned, Black American-owned, for-profit subchapter S corporation. The contract is for "PREP AND HIV ENVIRONMENTAL SCAN" services, which likely involves program evaluation, research, coordination, and dissemination related to public health initiatives, particularly in areas such as HIV/AIDS, substance abuse, mental health, and minority...
This federal contract award, with a ceiling value of $1,041.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of TRUVADA 200 MG-300 MG TABLET medication, a critical pharmaceutical product used in the treatment of various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 26, 2024. It is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $12,657.86 delivery order contract is for the supply of emtricitabine-tenofovir 200-300 mg tablets, which are used to treat HIV/AIDS. The contract has a ceiling value of $12,657.86 and runs through August 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,098.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a specialty medication used to treat HIV. The award was made under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
This federal contract award, valued at $20,985.59, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of TRUVADA 200 MG-300 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp maintains a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $81,768.73 Firm Fixed Price Delivery Order contract is for the supply of the pharmaceutical product Truvada, a medication used for the treatment of HIV. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as the primary...

This federal contract award, valued at $33,984,651.18, was made by the Department of Health and Human Services (HHS) to Mercalis Inc., a for-profit limited liability company, to expand patient access to HIV pre-exposure prophylaxis (PrEP) drugs. The contract is part of the HHS Office of the Assistant Secretary for Health's "Ending the HIV Epidemic: PrEP Implementation and Dissemination" program and will support the establishment and administration of a call center, online portal, eligibility verification process, pharmacy network, and enrollment database to distribute donated PrEP medications to qualified uninsured patients. The contract has a performance period of July 2020 through July 2025 and did not utilize a small business set-aside.

Generated 9/7/24, 12:18 PM